Commercial PRRS Modified-Live Virus Vaccines
Open Access
- 22 February 2021
- Vol. 9 (2), 185
- https://doi.org/10.3390/vaccines9020185
Abstract
Porcine reproductive and respiratory syndrome (PRRS) virus (PRRSV) presents one of the challenging viral pathogens in the global pork industry. PRRS is characterized by two distinct clinical presentations; reproductive failure in breeding animals (gilts, sows, and boars), and respiratory disease in growing pigs. PRRSV is further divided into two species: PRRSV-1 (formerly known as the European genotype 1) and PRRSV-2 (formerly known as the North American genotype 2). A PRRSV-2 modified-live virus (MLV) vaccine was first introduced in North America in 1994, and, six years later, a PRRSV-1 MLV vaccine was also introduced in Europe. Since then, MLV vaccination is the principal strategy used to control PRRSV infection. Despite the fact that MLV vaccines have shown some efficacy, they were problematic as the efficacy of vaccine was often unpredictable and depended highly on the field virus. This paper focused on the efficacy of commercially available MLV vaccines at a global level based on respiratory disease in growing pigs, and maternal and paternal reproductive failure in breeding animals.Funding Information
- BK 21 FOUR Future Veterinary Medicine Leading Education and Research Center (A0449-20200100)
This publication has 127 references indexed in Scilit:
- Comparative pathogenesis of type 1 (European genotype) and type 2 (North American genotype) porcine reproductive and respiratory syndrome virus in infected boarVirology Journal, 2013
- Immunization of pigs with a type 2 modified live PRRSV vaccine prevents the development of a deadly long lasting hyperpyrexia in a challenge study with highly pathogenic PRRSV JX143Vaccine, 2013
- Effect of the Modified Live Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Vaccine on European and North American PRRSV Shedding in Semen from Infected BoarsClinical and Vaccine Immunology, 2011
- Pathogenesis and antigenic characterization of a new East European subtype 3 porcine reproductive and respiratory syndrome virus isolateBMC Veterinary Research, 2010
- Age-dependent resistance to Porcine reproductive and respiratory syndrome virus replication in swineVirology Journal, 2009
- Highly Pathogenic Porcine Reproductive and Respiratory Syndrome, ChinaEmerging Infectious Diseases, 2007
- Emergence of Fatal PRRSV Variants: Unparalleled Outbreaks of Atypical PRRS in China and Molecular Dissection of the Unique HallmarkPLOS ONE, 2007
- Protection against Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Infection through Passive Transfer of PRRSV-Neutralizing Antibodies Is Dose DependentClinical and Vaccine Immunology, 2007
- Pathogenic and humoral immune responses to porcine reproductive and respiratory syndrome virus (PRRSV) are related to viral load in acute infectionVeterinary Immunology and Immunopathology, 2004
- Role of neutralizing antibodies in PRRSV protective immunityVeterinary Immunology and Immunopathology, 2004